Nuclear receptors in the cross-talk of drug metabolism and inflammation

Drug Metabolism Reviews

Volumn 45, Issue 1, 2013, Pages 122-144

  Gerbal Chaloin, Sabine ^a,b   Iankova, Irena ^a,b   Maurel, Patrick ^a,b   Daujat Chavanieu, Martine ^a,b,c  

^a INSERM   (France)

^b UNIV MONTPELLIER   (France)

^c HÔPITAL SAINT ELOI   (France)

Author keywords

AhR; CAR; CYP; Cytokines; GR; NF B; Nrf2; PXR; Xenosensors

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 7,12 DIMETHYLBENZ[A]ANTHRACENE; ACETYLCYSTEINE; ALLOPURINOL; AMINOGUANIDINE; AROMATIC HYDROCARBON RECEPTOR; ASCORBIC ACID; BAICALEIN; BAICALIN; BASIC HELIX LOOP HELIX LEUCINE ZIPPER TRANSCRIPTION FACTOR; BENZO[A]PYRENE; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CELL NUCLEUS RECEPTOR; CLOZAPINE; CONSTITUTIVE ANDROSTANE RECEPTOR; CYCLOSPORIN A; GLUCOCORTICOID RECEPTOR; MELATONIN; MIFEPRISTONE; PHENYTOIN; PREGNANE X RECEPTOR; PROTEIN KINASE C INHIBITOR; RETINOID X RECEPTOR; RIFAMPICIN; ROSIGLITAZONE; SMALL INTERFERING RNA; TACROLIMUS; UNINDEXED DRUG;

ANTIOXIDANT ACTIVITY; ASTROCYTOMA; CELL ACTIVITY; CROHN DISEASE; CYTOKINE RELEASE; DETOXIFICATION; DNA BINDING; DRUG CLEARANCE; DRUG METABOLISM; ENTERITIS; ENZYME ACTIVITY; GENE ACTIVATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; INFLAMMATION; LIVER CLEARANCE; MEDIATOR RELEASE; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; NONHUMAN; PRIMARY BILIARY CIRRHOSIS; PROMOTER REGION; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SUMOYLATION;

ANIMALS; HUMANS; INFLAMMATION; METABOLIC DETOXICATION, DRUG; RECEPTOR CROSS-TALK; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SIGNAL TRANSDUCTION;

EID: 84872726075     PISSN: 03602532     EISSN: 10979883     Source Type: Journal    
DOI: 10.3109/03602532.2012.756011     Document Type: Review

References (255)

1. Adcock, I. M., Caramori, G. (2001). Cross-talk between proinflammatory transcription factors and glucocorticoids. Immunol Cell Biol 79: 376-384. (Pubitemid 32744283)
2. Ahn, S. H., Shah, Y. M., Inoue, J., Morimura, K., Kim, I., Yim, S. et al. (2008). Hepatocyte nuclear factor 4alpha in the intestinal epithelial cells protects against inflammatory bowel disease. Inflamm Bowel Dis 14: 908-920.
3. Aitken, A. E., Richardson, T. A., Morgan, E. T. (2006). Regulation of drug-metabolizing enzymes and transporters in inflammation. Annu Rev Pharmacol Toxicol 46: 123-149. (Pubitemid 43271186)
4. Anwar-Mohamed, A., Degenhardt, O. S., El Gendy, M. A., Seubert, J. M., Kleeberger, S. R., El-Kadi, A. O. (2011). The effect of Nrf2 knockout on the constitutive expression of drug metabolizing enzymes and transporters in C57Bl/6 mice livers. Toxicol In Vitro 25: 785-795.
5. Anzenbacher, P. Anzenbacherová, E. (2001). Cytochromes P450 and metabolism of xenobiotics. Cell Mol Life Sci 58: 737-747. (Pubitemid 32553031)
6. Ashino, T., Oguro, T., Shioda, S., Horai, R., Asano, M., Sekikawa, K. et al. (2004). Involvement of interleukin-6 and tumor necrosis factor alpha in CYP3A11 and 2C29 down-regulation by Bacillus Calmette-Guerin and lipopolysaccharide in mouse liver. Drug Metab Dispos 32: 707-714. (Pubitemid 38821871)
7. Assenat, E., Gerbal-Chaloin, S., Larrey, D., Saric, J., Fabre, J. M., Maurel, P. et al. (2004). Interleukin 1beta inhibits CAR-induced expression of hepatic genes involved in drug and bilirubin clearance. Hepatology 40: 951-960. (Pubitemid 39288129)
8. Bachs, L., Parés, A., Elena, M., Piera, C., Rodés, J. (1992). Effects of long-term rifampicin administration in primary biliary cirrhosis. Gastroenterology 102: 2077-2080.
9. Barnes, P. J. (1997). Nuclear factor-kappa B. Int J Biochem Cell Biol 29: 867-870.
10. Barnes, P. J. (1998). Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin Sci (Lond) 94: 557-572. (Pubitemid 28269054)
11. Barnes, P. J., Karin, M. (1997). Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336: 1066-1071. (Pubitemid 27163860)
12. Beigneux, A. P., Moser, A. H., Shigenaga, J. K., Grunfeld, C., Feingold, K. R. (2000). The acute phase response is associated with retinoid X receptor repression in rodent liver. J Biol Chem 275: 16390-16399. (Pubitemid 30366957)
13. Beigneux, A. P., Moser, A. H., Shigenaga, J. K., Grunfeld, C., Feingold, K. R. (2002). Reduction in cytochrome P-450 enzyme expression is associated with repression of CAR (constitutive androstane receptor) and PXR (pregnane X receptor) in mouse liver during the acute phase response. Biochem Biophys Res Commun 293: 145-149. (Pubitemid 34694183)
14. Beischlag, T. V., Luis Morales, J., Hollingshead, B. D., Perdew, G. H. (2008). The aryl hydrocarbon receptor complex and the control of gene expression. Crit Rev Eukaryot Gene Expr 18: 207-250. (Pubitemid 351620286)
15. Bleau, A. M., Fradette, C., El-Kadi, A. O., Côté, M. C., du Souich, P. (2001). Cytochrome P450 down-regulation by serum from humans with a viral infection and from rabbits with an inflammatory reaction. Drug Metab Dispos 29: 1007-1012. (Pubitemid 32605916)
16. Bleau, A. M., Levitchi, M. C., Maurice, H., du Souich, P. (2000). Cytochrome P450 inactivation by serum from humans with a viral infection and serum from rabbits with a turpentine-induced inflammation: the role of cytokines. Br J Pharmacol 130: 1777-1784. (Pubitemid 30657504)
17. Bleau, A. M., Maurel, P., Pichette, V., Leblond, F., du Souich, P. (2003). Interleukin-1beta, interleukin-6, tumour necrosis factor-alpha and interferon-gamma released by a viral infection and an aseptic inflammation reduce CYP1A1, 1A2 and 3A6 expression in rabbit hepatocytes. Eur J Pharmacol 473: 197-206. (Pubitemid 36929885)
18. Blokzijl, H., Vander Borght, S., Bok, L. I., Libbrecht, L., Geuken, M., van den Heuvel, F. A. et al. (2007). Decreased P-glycoprotein (P-gp/MDR1) expression in inflamed human intestinal epithelium is independent of PXR protein levels. Inflamm Bowel Dis 13: 710-720. (Pubitemid 46909985)
19. Bolotin, E., Liao, H., Ta, T. C., Yang, C., Hwang-Verslues, W., Evans, J. R. et al. (2010). Integrated approach for the identification of human hepatocyte nuclear factor 4alpha target genes using protein binding microarrays. Hepatology 51: 642-653.
20. Bonizzi, G., Bebien, M., Otero, D. C., Johnson-Vroom, K. E., Cao, Y., Vu, D. et al. (2004). Activation of IKKalpha target genes depends on recognition of specific kappaB binding sites by RelB: p52 dimers. EMBO J 23: 4202-4210. (Pubitemid 39546158)
21. Bonizzi, G., Karin, M. (2004). The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol 25: 280-288. (Pubitemid 38610351)
22. Cain, B. S., Meldrum, D. R., Harken, A. H. (1999). Protein kinase C in normal and pathologic myocardial states. J Surg Res 81: 249-259. (Pubitemid 29397819)
23. Celius, T., Pansoy, A., Matthews, J., Okey, A. B., Henderson, M. C., Krueger, S. K. et al. (2010). Flavin-containing monooxygenase-3: induction by 3-methylcholanthrene and complex regulation by xenobiotic chemicals in hepatoma cells and mouse liver. Toxicol Appl Pharmacol 247: 60-69.
24. Celius, T., Roblin, S., Harper, P. A., Matthews, J., Boutros, P. C., Pohjanvirta, R. et al. (2008). Aryl hydrocarbon receptor-dependent induction of flavin-containing monooxygenase mRNAs in mouse liver. Drug Metab Dispos 36: 2499-2505.
25. Chang, L., Karin, M. (2001). Mammalian MAP kinase signalling cascades. Nature 410: 37-40. (Pubitemid 32225829)
26. Chen, K. J., Lin, S. Z., Zhou, L., Xie, H. Y., Zhou, W. H., Taki-Eldin, A. et al. (2011). Selective recruitment of regulatory T cell through CCR6-CCL20 in hepatocellular carcinoma fosters tumor progression and predicts poor prognosis. Plos One 6: e24671.
27. Chen, S., Operaña, T., Bonzo, J., Nguyen, N., Tukey, R. H. (2005a). ERK kinase inhibition stabilizes the aryl hydrocarbon receptor: implications for transcriptional activation and protein degradation. J Biol Chem 280: 4350-4359. (Pubitemid 41741355)
28. Chen, Y., Ferguson, S. S., Negishi, M., Goldstein, J. A. (2003). Identification of constitutive androstane receptor and glucocorticoid receptor binding sites in the CYP2C19 promoter. Mol Pharmacol 64: 316-324. (Pubitemid 36909995)
29. Chen, Y. H., Wang, J. P., Wang, H., Sun, M. F., Wei, L. Z., Wei, W. et al. (2005b). Lipopolysaccharide treatment downregulates the expression of the pregnane X receptor, cyp3a11 and mdr1a genes in mouse placenta. Toxicology 211: 242-252. (Pubitemid 40755258)
30. Chou, W. C., Prokova, V., Shiraishi, K., Valcourt, U., Moustakas, A., Hadzopoulou-Cladaras, M. et al. (2003). Mechanism of a transcriptional cross talk between transforming growth factorbeta-regulated Smad3 and Smad4 proteins and orphan nuclear receptor hepatocyte nuclear factor-4. Mol Biol Cell 14: 1279-1294. (Pubitemid 36337469)
31. Copple, I. M., Goldring, C. E., Kitteringham, N. R., Park, B. K. (2008). The Nrf2-Keap1 defence pathway: role in protection against druginduced toxicity. Toxicology 246: 24-33.
32. Coutinho, A. E., Chapman, K. E. (2011). The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights. Mol Cell Endocrinol 335: 2-13.
33. Dalton, T. P., Puga, A., Shertzer, H. G. (2002). Induction of cellular oxidative stress by aryl hydrocarbon receptor activation. Chem Biol Interact 141: 77-95. (Pubitemid 35223206)
34. De Bosscher, K., Haegeman, G. (2009). Minireview: latest perspectives on antiinflammatory actions of glucocorticoids. Mol Endocrinol 23: 281-291.
35. De Bosscher, K., Vanden Berghe, W., Haegeman, G. (2003). The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression. Endocr Rev 24: 488-522. (Pubitemid 37059110)
36. De Fabiani, E., Mitro, N., Anzulovich, A. C., Pinelli, A., Galli, G., Crestani, M. (2001). The negative effects of bile acids and tumor necrosis factor-alpha on the transcription of cholesterol 7alphahydroxylase gene (CYP7A1) converge to hepatic nuclear factor-4: a novel mechanism of feedback regulation of bile acid synthesis mediated by nuclear receptors. J Biol Chem 276: 30708-30716.
37. De Souza, V. R., Cabrera, W. K., Galvan, A., Ribeiro, O. G., De Franco, M., Vorraro, F. et al. (2009). Aryl hydrocarbon receptor polymorphism modulates DMBA-induced inflammation and carcinogenesis in phenotypically selected mice. Int J Cancer 124: 1478-1482.
38. Deng, Y., Theken, K. N., Lee, C. R. (2010). Cytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammation. J Mol Cell Cardiol 48: 331-341.
39. Denison, M. S., Nagy, S. R. (2003). Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu Rev Pharmacol Toxicol 43: 309-334. (Pubitemid 37372644)
40. Denson, L. A., Auld, K. L., Schiek, D. S., McClure, M. H., Mangelsdorf, D. J., Karpen, S. J. (2000). Interleukin-1beta suppresses retinoid transactivation of two hepatic transporter genes involved in bile formation. J Biol Chem 275: 8835-8843. (Pubitemid 30180239)
41. Dickmann, L. J., Patel, S. K., Wienkers, L. C., Slatter, J. G. (2012). Effects of interleukin 1ß (IL-1ß) and IL-1ß/interleukin 6 (IL-6) combinations on drug metabolizing enzymes in human hepatocyte culture. Curr Drug Metab 13: 930-937.
42. DiNatale, B. C., Schroeder, J. C., Perdew, G. H. (2011). Ah receptor antagonism inhibits constitutive and cytokine inducible IL6 production in head and neck tumor cell lines. Mol Carcinog 50: 173-183.
43. Ding, X., Staudinger, J. L. (2005). Repression of PXR-mediated induction of hepatic CYP3A gene expression by protein kinase C. Biochem Pharmacol 69: 867-873. (Pubitemid 40248628)
44. Diry, M., Tomkiewicz, C., Koehle, C., Coumoul, X., Bock, K. W., Barouki, R. et al. (2006). Activation of the dioxin/aryl hydrocarbon receptor (AhR) modulates cell plasticity through a JNK-dependent mechanism. Oncogene 25: 5570-5574. (Pubitemid 44344107)
45. Dou, W., Mukherjee, S., Li, H., Venkatesh, M., Wang, H., Kortagere, S. et al. (2012). Alleviation of gut inflammation by Cdx2/Pxr pathway in a mouse model of chemical colitis. Plos One 7: e36075.
46. Dring, M. M., Goulding, C. A., Trimble, V. I., Keegan, D., Ryan, A. W., Brophy, K. M. et al. (2006). The pregnane X receptor locus is associated with susceptibility to inflammatory bowel disease. Gastroenterology 130: 341-8; quiz 592. (Pubitemid 43202034)
47. Dubrac, S., Elentner, A., Ebner, S., Horejs-Hoeck, J., Schmuth, M. (2010). Modulation of T lymphocyte function by the pregnane X receptor. J Immunol 184: 2949-2957.
48. Duret, C., Daujat-Chavanieu, M., Pascussi, J. M., Pichard-Garcia, L., Balaguer, P., Fabre, J. M. et al. (2006). Ketoconazole and miconazole are antagonists of the human glucocorticoid receptor: consequences on the expression and function of the constitutive androstane receptor and the pregnane X receptor. Mol Pharmacol 70: 329-339.
49. Duret, C., Gerbal-Chaloin, S., Ramos, J., Fabre, J. M., Jacquet, E., Navarro, F. et al. (2007). Isolation, characterization, and differentiation to hepatocyte-like cells of nonparenchymal epithelial cells from adult human liver. Stem Cells 25: 1779-1790. (Pubitemid 47121857)
50. El-Kadi, A. O., Bleau, A. M., Dumont, I., Maurice, H., du Souich, P. (2000). Role of reactive oxygen intermediates in the decrease of hepatic cytochrome P450 activity by serum of humans and rabbits with an acute inflammatory reaction. Drug Metab Dispos 28: 1112-1120. (Pubitemid 30660368)
51. Ernst, P. (1999). Review article: the role of inflammation in the pathogenesis of gastric cancer. Aliment Pharmacol Ther 13 Suppl 1: 13-18. (Pubitemid 29142255)
52. Fan, J., Maeng, H. J., Du, Y., Kwan, D., Pang, K. S. (2011). Transport of 5,5-diphenylbarbituric acid and its precursors and their effect on P-gp, MRP2 and CYP3A4 in Caco-2 and LS180 cells. Eur J Pharm Sci 42: 19-29.
53. Fang, C., Yoon, S., Tindberg, N., Järveläinen, H. A., Lindros, K. O., Ingelman-Sundberg, M. (2004). Hepatic expression of multiple acute phase proteins and down-regulation of nuclear receptors after acute endotoxin exposure. Biochem Pharmacol 67: 1389-1397. (Pubitemid 38315104)
54. Favreau, L. V., Pickett, C. B. (1991). Transcriptional regulation of the rat NAD(P)H: quinone reductase gene. Identification of regulatory elements controlling basal level expression and inducible expression by planar aromatic compounds and phenolic antioxidants. J Biol Chem 266: 4556-4561. (Pubitemid 21909392)
55. Feghali, C. A., Wright, T. M. (1997). Cytokines in acute and chronic inflammation. Front Biosci 2: d12-d26.
56. Ferguson, S. S., Chen, Y., LeCluyse, E. L., Negishi, M., Goldstein, J. A. (2005). Human CYP2C8 is transcriptionally regulated by the nuclear receptors constitutive androstane receptor, pregnane X receptor, glucocorticoid receptor, and hepatic nuclear factor 4alpha. Mol Pharmacol 68: 747-757. (Pubitemid 41206028)
57. Fisher, C. D., Lickteig, A. J., Augustine, L. M., Ranger-Moore, J., Jackson, J. P., Ferguson, S. S. et al. (2009). Hepatic cytochrome P450 enzyme alterations in humans with progressive stages of nonalcoholic fatty liver disease. Drug Metab Dispos 37: 2087-2094.
58. Fujii-Kuriyama, Y., Kawajiri, K. (2010). Molecular mechanisms of the physiological functions of the aryl hydrocarbon (dioxin) receptor, a multifunctional regulator that senses and responds to environmental stimuli. Proc Jpn Acad Ser B Phys Biol Sci 86: 40-53.
59. Gabay, C., Kushner, I. (1999). Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340: 448-454. (Pubitemid 29084777)
60. Gajjar, K., Martin-Hirsch, P. L., Martin, F. L. (2012). CYP1B1 and hormone-induced cancer. Cancer Lett 324: 13-30.
61. Gao, B., Wang, H., Lafdil, F., Feng, D. (2012). STAT proteins-key regulators of anti-viral responses, inflammation, and tumorigenesis in the liver. J Hepatol 57: 430-441.
62. Geier, A., Dietrich, C. G., Voigt, S., Kim, S. K., Gerloff, T., Kullak-Ublick, G. A. et al. (2003). Effects of proinflammatory cytokines on rat organic anion transporters during toxic liver injury and cholestasis. Hepatology 38: 345-354. (Pubitemid 36919855)
63. Geiss-Friedlander, R., Melchior, F. (2007). Concepts in sumoylation: a decade on. Nat Rev Mol Cell Biol 8: 947-956. (Pubitemid 350176509)
64. Gerbal-Chaloin, S., Daujat, M., Pascussi, J. M., Pichard-Garcia, L., Vilarem, M. J., Maurel, P. (2002). Transcriptional regulation of CYP2C9 gene. Role of glucocorticoid receptor and constitutive androstane receptor. J Biol Chem 277: 209-217. (Pubitemid 34952047)
65. Germain, P., Staels, B., Dacquet, C., Spedding, M., Laudet, V. (2006). Overview of nomenclature of nuclear receptors. Pharmacol Rev 58: 685-704. (Pubitemid 44833739)
66. Gharavi, N., El-Kadi, A. O. (2005). Down-regulation of aryl hydrocarbon receptor-regulated genes by tumor necrosis factor-alpha and lipopolysaccharide in murine hepatoma Hepa 1c1c7 cells. J Pharm Sci 94: 493-506. (Pubitemid 40476515)
67. Gharavi, N., El-Kadi, A. O. (2007). Role of nitric oxide in downregulation of cytochrome P450 1a1 and NADPH: Quinone oxidoreductase 1 by tumor necrosis factor-alpha and lipopolysaccharide. J Pharm Sci 96: 2795-2807. (Pubitemid 47597828)
68. Ghose, R., Mulder, J., von Furstenberg, R. J., Thevananther, S., Kuipers, F., Karpen, S. J. (2007). Rosiglitazone attenuates suppression of RXRalpha-dependent gene expression in inflamed liver. J Hepatol 46: 115-123. (Pubitemid 44827424)
69. Ghose, R., Zimmerman, T. L., Thevananther, S., Karpen, S. J. (2004). Endotoxin leads to rapid subcellular re-localization of hepatic RXRalpha: A novel mechanism for reduced hepatic gene expression in inflammation. Nucl Recept 2: 4.
70. Giannini, E., Fasoli, A., Botta, F., Romagnoli, P., Malfatti, F., Chiarbonello, B. et al. (2003). Helicobacter pylori infection is associated with greater impairment of cytochrome P-450 liver metabolic activity in anti-HCV positive cirrhotic patients. Dig Dis Sci 48: 802-808. (Pubitemid 36390688)
71. Glas, J., Seiderer, J., Fischer, D., Tengler, B., Pfennig, S., Wetzke, M. et al. (2011). Pregnane X receptor (PXR/NR1I2) gene haplotypes modulate susceptibility to inflammatory bowel disease. Inflamm Bowel Dis 17: 1917-1924.
72. Gu, X., Ke, S., Liu, D., Sheng, T., Thomas, P. E., Rabson, A. B. et al. (2006). Role of NF-kappaB in regulation of PXR-mediated gene expression: a mechanism for the suppression of cytochrome P-450 3A4 by proinflammatory agents. J Biol Chem 281: 17882-17889. (Pubitemid 44035587)
73. Haack, M. J., Bak, M. L., Beurskens, R., Maes, M., Stolk, L. M., Delespaul, P. A. (2003). Toxic rise of clozapine plasma concentrations in relation to inflammation. Eur Neuropsychopharmacol 13: 381-385. (Pubitemid 37040921)
74. Hankinson, O. (1995). The aryl hydrocarbon receptor complex. Annu Rev Pharmacol Toxicol 35: 307-340.
75. Henkler, F., Stolpmann, K., Luch, A. (2012). Exposure to polycyclic aromatic hydrocarbons: bulky DNA adducts and cellular responses. Exs 101: 107-131.
76. Henklova, P., Vrzal, R., Papouskova, B., Bednar, P., Jancova, P., Anzenbacherova, E. et al. (2008a). SB203580, a pharmacological inhibitor of p38 MAP kinase transduction pathway activates ERK and JNK MAP kinases in primary cultures of human hepatocytes. Eur J Pharmacol 593: 16-23.
77. Henklová, P., Vrzal, R., Ulrichová, J., Dvorák, Z. (2008b). Role of mitogen-activated protein kinases in aryl hydrocarbon receptor signaling. Chem Biol Interact 172: 93-104.
78. Ho, G. T., Soranzo, N., Tate, S. K., Drummond, H., Nimmo, E. R., Tenesa, A. et al. (2006). Lack of association of the pregnane X receptor (PXR/NR1I2) gene with inflammatory bowel disease: parallel allelic association study and gene wide haplotype analysis. Gut 55: 1676-1677. (Pubitemid 44629238)
79. Hoffer, A., Chang, C. Y., Puga, A. (1996). Dioxin induces transcription of fos and jun genes by Ah receptor-dependent and-independent pathways. Toxicol Appl Pharmacol 141: 238-247. (Pubitemid 26414370)
80. Hollingshead, B. D., Beischlag, T. V., Dinatale, B. C., Ramadoss, P., Perdew, G. H. (2008). Inflammatory signaling and aryl hydrocarbon receptor mediate synergistic induction of interleukin 6 in MCF-7 cells. Cancer Res 68: 3609-3617.
81. Holt, M. P., Ju, C. (2006). Mechanisms of drug-induced liver injury. AAPS J 8: E48-E54. (Pubitemid 44603865)
82. Hsu, H. Y., Wen, M. H. (2002). Lipopolysaccharide-mediated reactive oxygen species and signal transduction in the regulation of interleukin-1 gene expression. J Biol Chem 277: 22131-22139.
83. Hu, G., Xu, C., Staudinger, J. L. (2010). Pregnane X receptor is SUMOylated to repress the inflammatory response. J Pharmacol Exp Ther 335: 342-350.
84. Huang, H., Wang, H., Sinz, M., Zoeckler, M., Staudinger, J., Redinbo, M. R. et al. (2007). Inhibition of drug metabolism by blocking the activation of nuclear receptors by ketoconazole. Oncogene 26: 258-268. (Pubitemid 46095736)
85. Hybertson, B. M., Gao, B., Bose, S. K., McCord, J. M. (2011). Oxidative stress in health and disease: the therapeutic potential of Nrf2 activation. Mol Aspects Med 32: 234-246.
86. Ikuta, T., Kobayashi, Y., Kawajiri, K. (2004). Cell density regulates intracellular localization of aryl hydrocarbon receptor. J Biol Chem 279: 19209-19216. (Pubitemid 38623352)
87. Johnson, C., Han, Y., Hughart, N., McCarra, J., Alpini, G., Meng, F. (2012). Interleukin-6 and its receptor, key players in hepatobiliary inflammation and cancer. Transl Gastrointest Cancer 1: 58-70.
88. Kacevska, M., Robertson, G. R., Clarke, S. J., Liddle, C. (2008). Inflammation and CYP3A4-mediated drug metabolism in advanced cancer: impact and implications for chemotherapeutic drug dosing. Expert Opin Drug Metab Toxicol 4: 137-149. (Pubitemid 351308413)
89. Kamiya, A., Inoue, Y., Gonzalez, F. J. (2003). Role of the hepatocyte nuclear factor 4alpha in control of the pregnane X receptor during fetal liver development. Hepatology 37: 1375-1384. (Pubitemid 36667318)
90. Kassel, O., Herrlich, P. (2007). Crosstalk between the glucocorticoid receptor and other transcription factors: molecular aspects. Mol Cell Endocrinol 275: 13-29. (Pubitemid 47259283)
91. Kawamoto, T., Sueyoshi, T., Zelko, I., Moore, R., Washburn, K., Negishi, M. (1999). Phenobarbital-responsive nuclear translocation of the receptor CAR in induction of the CYP2B gene. Mol Cell Biol 19: 6318-6322. (Pubitemid 29399336)
92. Ke, S., Rabson, A. B., Germino, J. F., Gallo, M. A., Tian, Y. (2001). Mechanism of suppression of cytochrome P-450 1A1 expression by tumor necrosis factor-alpha and lipopolysaccharide. J Biol Chem 276: 39638-39644.
93. Kensler, T. W., Wakabayashi, N., Biswal, S. (2007). Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol 47: 89-116.
94. Kerkvliet, N. I., Shepherd, D. M., Baecher-Steppan, L. (2002). T lymphocytes are direct, aryl hydrocarbon receptor (AhR)-dependent targets of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): AhR expression in both CD4+ and CD8+ T cells is necessary for full suppression of a cytotoxic T lymphocyte response by TCDD. Toxicol Appl Pharmacol 185: 146-152. (Pubitemid 36062805)
95. Kim, D. W., Gazourian, L., Quadri, S. A., Romieu-Mourez, R., Sherr, D. H., Sonenshein, G. E. (2000). The RelA NF-kappaB subunit and the aryl hydrocarbon receptor (AhR) cooperate to transactivate the c-myc promoter in mammary cells. Oncogene 19: 5498-5506. (Pubitemid 32000917)
96. Kim, J. Y., Lee, S. M. (2006). Vitamins C and E protect hepatic cytochrome P450 dysfunction induced by polymicrobial sepsis. Eur J Pharmacol 534: 202-209.
97. Kimura, A., Naka, T., Nakahama, T., Chinen, I., Masuda, K., Nohara, K. et al. (2009). Aryl hydrocarbon receptor in combination with Stat1 regulates LPS-induced inflammatory responses. J Exp Med 206: 2027-2035.
98. Kimura, A., Naka, T., Nohara, K., Fujii-Kuriyama, Y., Kishimoto, T. (2008). Aryl hydrocarbon receptor regulates Stat1 activation and participates in the development of Th17 cells. Proc Natl Acad Sci USA 105: 9721-9726. (Pubitemid 352031367)
99. Kobayashi, A., Numayama-Tsuruta, K., Sogawa, K., Fujii-Kuriyama, Y. (1997). CBP/p300 functions as a possible transcriptional coactivator of Ah receptor nuclear translocator (Arnt). J Biochem 122: 703-710. (Pubitemid 27474937)
100. Kobayashi, S., Okamoto, H., Iwamoto, T., Toyama, Y., Tomatsu, T., Yamanaka, H. et al. (2008). A role for the aryl hydrocarbon receptor and the dioxin TCDD in rheumatoid arthritis. Rheumatology (Oxford) 47: 1317-1322.
101. Köhle, C. Bock, K. W. (2007). Coordinate regulation of Phase I and II xenobiotic metabolisms by the Ah receptor and Nrf2. Biochem Pharmacol 73: 1853-1862. (Pubitemid 46677898)
102. Köhle, C., Bock, K. W. (2009). Coordinate regulation of human drugmetabolizing enzymes, and conjugate transporters by the Ah receptor, pregnane X receptor and constitutive androstane receptor. Biochem Pharmacol 77: 689-699.
103. Koike, C., Moore, R., Negishi, M. (2007). Extracellular signal-regulated kinase is an endogenous signal retaining the nuclear constitutive active/androstane receptor (CAR) in the cytoplasm of mouse primary hepatocytes. Mol Pharmacol 71: 1217-1221. (Pubitemid 46658675)
104. Korashy, H. M., Anwar-Mohamed, A., Soshilov, A. A., Denison, M. S., El-Kadi, A. O. (2011). The p38 MAPK inhibitor SB203580 induces cytochrome P450 1A1 gene expression in murine and human hepatoma cell lines through ligand-dependent aryl hydrocarbon receptor activation. Chem Res Toxicol 24: 1540-1548.
105. Korashy, H. M., El-Kadi, A. O. (2008). The role of redox-sensitive transcription factors NF-kappaB and AP-1 in the modulation of the Cyp1a1 gene by mercury, lead, and copper. Free Radic Biol Med 44: 795-806.
106. Kosters, A., White, D. D., Sun, H., Thevananther, S., Karpen, S. J. (2009). Redundant roles for cJun-N-terminal kinase 1 and 2 in interleukin-1beta-mediated reduction and modification of murine hepatic nuclear retinoid X receptor alpha. J Hepatol 51: 898-908.
107. Kumar, M. B., Perdew, G. H. (1999). Nuclear receptor coactivator SRC-1 interacts with the Q-rich subdomain of the AhR and modulates its transactivation potential. Gene Expr 8: 273-286. (Pubitemid 30637487)
108. Kyriakis, J. M., Avruch, J. (2012). Mammalian MAPK signal transduction pathways activated by stress and inflammation: a 10-year update. Physiol Rev 92: 689-737.
109. Lambert, C. B., Spire, C., Claude, N., Guillouzo, A. (2009). Dose-and time-dependent effects of phenobarbital on gene expression profiling in human hepatoma HepaRG cells. Toxicol Appl Pharmacol 234: 345-360.
110. Lecureur, V., Ferrec, E. L., N'diaye, M., Vee, M. L., Gardyn, C., Gilot, D. et al. (2005). ERK-dependent induction of TNFalpha expression by the environmental contaminant benzo(a)pyrene in primary human macrophages. Febs Letters 579: 1904-1910. (Pubitemid 40404029)
111. Lee, J. H., Park, S. M., Kim, O. S., Lee, C. S., Woo, J. H., Park, S. J. et al. (2009). Differential SUMOylation of LXRalpha and LXRbeta mediates transrepression of STAT1 inflammatory signaling in IFNgamma-stimulated brain astrocytes. Mol Cell 35: 806-817.
112. Lee, J. S., Kim, K. I., Baek, S. H. (2008). Nuclear receptors and coregulators in inflammation and cancer. Cancer Lett 267: 189-196.
113. Lehmann, J. M., McKee, D. D., Watson, M. A., Willson, T. M., Moore, J. T., Kliewer, S. A. (1998). The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J Clin Invest 102: 1016-1023. (Pubitemid 28419246)
114. Li, N., Klaassen, C. D. (2004). Role of liver-enriched transcription factors in the down-regulation of organic anion transporting polypeptide 4 (oatp4; oatplb2; slc21a10) by lipopolysaccharide. Mol Pharmacol 66: 694-701. (Pubitemid 39329269)
115. Li, T., Jahan, A., Chiang, J. Y. (2006). Bile acids and cytokines inhibit the human cholesterol 7 alpha-hydroxylase gene via the JNK/c-jun pathway in human liver cells. Hepatology 43: 1202-1210. (Pubitemid 43980098)
116. Li, T., Yu, R. T., Atkins, A. R., Downes, M., Tukey, R. H., Evans, R. M. (2012). Targeting the pregnane X receptor in liver injury. Expert Opin Ther Targets 16: 1075-1083.
117. Li, W., Vogel, C. F., Wu, D., Matsumura, F. (2010). Non-genomic action of TCDD to induce inflammatory responses in HepG2 human hepatoma cells and in liver of C57BL/6J mice. Biol Chem 391: 1205-1219.
118. Long, W. P., Pray-Grant, M., Tsai, J. C., Perdew, G. H. (1998). Protein kinase C activity is required for aryl hydrocarbon receptor pathwaymediated signal transduction. Mol Pharmacol 53: 691-700. (Pubitemid 28196492)
119. Ma, Q. (2008). Xenobiotic-activated receptors: from transcription to drug metabolism to disease. Chem Res Toxicol 21: 1651-1671.
120. Ma, Q. (2011). Influence of light on aryl hydrocarbon receptor signaling and consequences in drug metabolism, physiology and disease. Expert Opin Drug Metab Toxicol 7: 1267-1293.
121. Ma, Q., Kinneer, K., Bi, Y., Chan, J. Y., Kan, Y. W. (2004). Induction of murine NAD(P)H: quinone oxidoreductase by 2,3,7,8-tetrachlorodibenzo-p-dioxin requires the CNC (cap 'n' collar) basic leucine zipper transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2): cross-interaction between AhR (aryl hydrocarbon receptor) and Nrf2 signal transduction. Biochem J 377: 205-213. (Pubitemid 38114447)
122. Majkova, Z., Smart, E., Toborek, M., Hennig, B. (2009). Up-regulation of endothelial monocyte chemoattractant protein-1 by coplanar PCB77 is caveolin-1-dependent. Toxicol Appl Pharmacol 237: 1-7.
123. Malaplate-Armand, C., Ferrari, L., Masson, C., Siest, G., Batt, A. M. (2003). Astroglial CYP1B1 up-regulation in inflammatory/oxidative toxic conditions: IL-1beta effect and protection by N-acetylcysteine. Toxicol Lett 138: 243-251. (Pubitemid 36135927)
124. Mannering, G. J. (1986). Measurement of effect of interferon on drug metabolism. Methods Enzymol 119: 718-725. (Pubitemid 16025180)
125. Mannering, G. J., Renton, K. W., el Azhary, R., Deloria, L. B. (1980). Effects of interferon-inducing agents on hepatic cytochrome P-450 drug metabolizing systems. Ann N Y Acad Sci 350: 314-331.
126. Marchand, A., Barouki, R., Garlatti, M. (2004). Regulation of NAD(P) H: quinone oxidoreductase 1 gene expression by CYP1A1 activity. Mol Pharmacol 65: 1029-1037. (Pubitemid 38420509)
127. Masubuchi, Y., Horie, T. (2004). Endotoxin-mediated disturbance of hepatic cytochrome P450 function and development of endotoxin tolerance in the rat model of dextran sulfate sodium-induced experimental colitis. Drug Metab Dispos 32: 437-441. (Pubitemid 38420278)
128. Masubuchi, Y., Sugiyama, S., Horie, T. (2009). Th1/Th2 cytokine balance as a determinant of acetaminophen-induced liver injury. Chem Biol Interact 179: 273-279.
129. Matsumura, F. (2009). The significance of the nongenomic pathway in mediating inflammatory signaling of the dioxin-activated Ah receptor to cause toxic effects. Biochem Pharmacol 77: 608-626.
130. McFadyen, M. C., Murray, G. I. (2005). Cytochrome P450 1B1: a novel anticancer therapeutic target. Future Oncology (London, England) 1: 259-263.
131. McKay, L. I., Cidlowski, J. A. (1999). Molecular control of immune/inflammatory responses: interactions between nuclear factorkappa B and steroid receptor-signaling pathways. Endocr Rev 20: 435-459. (Pubitemid 30648895)
132. McKay, L. I., Cidlowski, J. A. (2000). CBP (CREB binding protein) integrates NF-kappaB (nuclear factor-kappaB) and glucocorticoid receptor physical interactions and antagonism. Mol Endocrinol 14: 1222-1234. (Pubitemid 32260483)
133. Mencarelli, A., Renga, B., Palladino, G., Claudio, D., Ricci, P., Distrutti, E. et al. (2011). Inhibition of NF-B by a PXR-dependent pathway mediates counter-regulatory activities of rifaximin on innate immunity in intestinal epithelial cells. Eur J Pharmacol 668: 317-324.
134. Miao, W., Hu, L., Scrivens, P. J., Batist, G. (2005). Transcriptional regulation of NF-E2 p45-related factor (NRF2) expression by the aryl hydrocarbon receptor-xenobiotic response element signaling pathway: direct cross-talk between phase I and II drugmetabolizing enzymes. J Biol Chem 280: 20340-20348. (Pubitemid 40776732)
135. Monteiro, P., Gilot, D., Langouet, S., Fardel, O. (2008). Activation of the aryl hydrocarbon receptor by the calcium/calmodulin-dependent protein kinase kinase inhibitor 7-oxo-7H-benzimidazo[2,1-a] benz[de]isoquinoline-3-carboxylic acid (STO-609). Drug Metab Dispos 36: 2556-2563.
136. Monteleone, I., MacDonald, T. T., Pallone, F., Monteleone, G. (2012). The aryl hydrocarbon receptor in inflammatory bowel disease: linking the environment to disease pathogenesis. Curr Opin Gastroenterol 28: 310-313.
137. Moore, L. B., Parks, D. J., Jones, S. A., Bledsoe, R. K., Consler, T. G., Stimmel, J. B. et al. (2000). Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands. J Biol Chem 275: 15122-15127. (Pubitemid 30337234)
138. Moreau, A., Vilarem, M. J., Maurel, P., Pascussi, J. M. (2008). Xenoreceptors CAR and PXR activation and consequences on lipid metabolism, glucose homeostasis, and inflammatory response. Mol Pharm 5: 35-41. (Pubitemid 351300032)
139. Morgan, E. T. (1997). Regulation of cytochromes P450 during inflammation and infection. Drug Metab Rev 29: 1129-1188. (Pubitemid 28133460)
140. Morgan, E. T. (2001). Regulation of cytochrome p450 by inflammatory mediators: why and how? Drug Metab Dispos 29: 207-212. (Pubitemid 32179517)
141. Morgan, E. T. (2009). Impact of infectious and inflammatory disease on cytochrome P450-mediated drug metabolism and pharmacokinetics. Clin Pharmacol Ther 85: 434-438.
142. Morgan, E. T., Goralski, K. B., Piquette-Miller, M., Renton, K. W., Robertson, G. R., Chaluvadi, M. R. et al. (2008). Regulation of drug-metabolizing enzymes and transporters in infection, inflammation, and cancer. Drug Metab Dispos 36: 205-216. (Pubitemid 351185732)
143. Moriya, N., Kataoka, H., Fujino, H., Nishikawa, J., Kugawa, F. (2012). Effect of lipopolysaccharide on the xenobiotic-induced expression and activity of hepatic cytochrome P450 in mice. Biol Pharm Bull 35: 473-480.
144. Moshage, H. (1997). Cytokines and the hepatic acute phase response. J Pathol 181: 257-266. (Pubitemid 27156836)
145. Mottet, C., Golshayan, D. (2007). CD4+CD25+Foxp3+ regulatory T cells: from basic research to potential therapeutic use. Swiss Med Wkly 137: 625-634. (Pubitemid 350189579)
146. Muntané-Relat, J., Ourlin, J. C., Domergue, J., Maurel, P. (1995). Differential effects of cytokines on the inducible expression of CYP1A1, CYP1A2, and CYP3A4 in human hepatocytes in primary culture. Hepatology 22(4 Pt 1): 1143-1153.
147. Murray, G. I. (2000). The role of cytochrome P450 in tumour development and progression and its potential in therapy. J Pathol 192: 419-426.
148. Murray, G. I., Melvin, W. T., Greenlee, W. F., Burke, M. D. (2001). Regulation, function, and tissue-specific expression of cytochrome P450 CYP1B1. Annu Rev Pharmacol Toxicol 41: 297-316. (Pubitemid 32390115)
149. Mutoh, S., Osabe, M., Inoue, K., Moore, R., Pedersen, L., Perera, L. et al. (2009). Dephosphorylation of threonine 38 is required for nuclear translocation and activation of human xenobiotic receptor CAR (NR1I3). J Biol Chem 284: 34785-34792.
150. N'Diaye, M., Le Ferrec, E., Lagadic-Gossmann, D., Corre, S., Gilot, D., Lecureur, V. et al. (2006). Aryl hydrocarbon receptor-and calciumdependent induction of the chemokine CCL1 by the environmental contaminant benzo[a]pyrene. J Biol Chem 281: 19906-19915. (Pubitemid 44065764)
151. Nikolaidou-Neokosmidou, V., Zannis, V. I., Kardassis, D. (2006). Inhibition of hepatocyte nuclear factor 4 transcriptional activity by the nuclear factor kappaB pathway. Biochem J 398: 439-450. (Pubitemid 44453388)
152. Nolin, T. D. (2010). On warfarin use in kidney disease: a therapeutic window of opportunity? Am J Kidney Dis 56: 805-808.
153. Nones, K., Dommels, Y. E., Martell, S., Butts, C., McNabb, W. C., Park, Z. A. et al. (2009). The effects of dietary curcumin and rutin on colonic inflammation and gene expression in multidrug resistance gene-deficient (mdr1a-/-) mice, a model of Br J Nutr 101: 169-181.
154. Opitz, C. A., Litzenburger, U. M., Sahm, F., Ott, M., Tritschler, I., Trump, S. et al. (2011). An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor. Nature 478: 197-203.
155. Osabe, M., Negishi, M. (2011). Active ERK1/2 protein interacts with the phosphorylated nuclear constitutive active/androstane receptor (CAR; NR1I3), repressing dephosphorylation and sequestering CAR in the cytoplasm. J Biol Chem 286: 35763-35769.
156. Papa, S., Zazzeroni, F., Bubici, C., Jayawardena, S., Alvarez, K., Matsuda, S. et al. (2004). Gadd45 beta mediates the NF-kappa B suppression of JNK signalling by targeting MKK7/JNKK2. Nat Cell Biol 6: 146-153. (Pubitemid 38425714)
157. Park, S. J., Yoon, W. K., Kim, H. J., Son, H. Y., Cho, S. W., Jeong, K. S. et al. (2005). 2,3,7,8-Tetrachlorodibenzo-p-dioxin activates ERK and p38 mitogen-activated protein kinases in RAW 264.7 cells. Anticancer Res 25: 2831-2836.
158. Pascual, G., Fong, A. L., Ogawa, S., Gamliel, A., Li, A. C., Perissi, V. et al. (2005). A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma. Nature 437: 759-763. (Pubitemid 41486547)
159. Pascussi, J. M., Gerbal-Chaloin, S., Drocourt, L., Assénat, E., Larrey, D., Pichard-Garcia, L. et al. (2004). Cross-talk between xenobiotic detoxication and other signalling pathways: clinical and toxicological consequences. Xenobiotica 34: 633-664. (Pubitemid 39486045)
160. Pascussi, J. M., Gerbal-Chaloin, S., Duret, C., Daujat-Chavanieu, M., Vilarem, M. J., Maurel, P. (2008). The tangle of nuclear receptors that controls xenobiotic metabolism and transport: crosstalk and consequences. Annu Rev Pharmacol Toxicol 48: 1-32. (Pubitemid 351738147)
161. Pascussi, J. M., Gerbal-Chaloin, S., Fabre, J. M., Maurel, P., Vilarem, M. J. (2000a). Dexamethasone enhances constitutive androstane receptor expression in human hepatocytes: consequences on cytochrome P450 gene regulation. Mol Pharmacol 58: 1441-1450.
162. Pascussi, J. M., Gerbal-Chaloin, S., Pichard-Garcia, L., Daujat, M., Fabre, J. M., Maurel, P. et al. (2000b). Interleukin-6 negatively regulates the expression of pregnane X receptor and constitutively activated receptor in primary human hepatocytes. Biochem Biophys Res Commun 274: 707-713. (Pubitemid 30663683)
163. Pascussi, J. M., Robert, A., Moreau, A., Ramos, J., Bioulac-Sage, P., Navarro, F. et al. (2007). Differential regulation of constitutive androstane receptor expression by hepatocyte nuclear factor4alpha isoforms. Hepatology 45: 1146-1153. (Pubitemid 46775776)
164. Patel, R. D., Murray, I. A., Flaveny, C. A., Kusnadi, A., Perdew, G. H. (2009). Ah receptor represses acute-phase response gene expression without binding to its cognate response element. Lab Invest 89: 695-707.
165. Paunescu, E. (1970). In vivo and in vitro suppression of humoral and cellular immunological response by rifampicin. Nature 228: 1188-1190.
166. Pedruzzi, L. M., Stockler-Pinto, M. B., Leite, M. Jr., Mafra, D. (2012). Nrf2-keap1 system versus NF-B: the good and the evil in chronic kidney disease? Biochimie 94: 2461-2466.
167. Pereira, T. M., Carlstedt-Duke, J., Lechner, M. C., Gustafsson, J. A. (1998). Identification of a functional glucocorticoid response element in the CYP3A1/IGC2 gene. DNA Cell Biol 17: 39-49. (Pubitemid 28084082)
168. Piscaglia, F., Knittel, T., Kobold, D., Barnikol-Watanabe, S., Di Rocco, P., Ramadori, G. (1999). Cellular localization of hepatic cytochrome 1B1 expression and its regulation by aromatic hydrocarbons and inflammatory cytokines. Biochem Pharmacol 58: 157-165. (Pubitemid 29246084)
169. Pondugula, S. R., Dong, H., Chen, T. (2009). Phosphorylation and protein-protein interactions in PXR-mediated CYP3A repression. Expert Opin Drug Metab Toxicol 5: 861-873.
170. Puga, A., Ma, C., Marlowe, J. L. (2009). The aryl hydrocarbon receptor cross-talks with multiple signal transduction pathways. Biochem Pharmacol 77: 713-722.
171. Puga, A., Nebert, D. W., Carrier, F. (1992). Dioxin induces expression of c-fos and c-jun proto-oncogenes and a large increase in transcription factor AP-1. DNA Cell Biol 11: 269-281.
172. Puga, A., Xia, Y., Elferink, C. (2002). Role of the aryl hydrocarbon receptor in cell cycle regulation. Chem Biol Interact 141: 117-130. (Pubitemid 35223208)
173. Radjendirane, V., Jaiswal, A. K. (1999). Antioxidant response elementmediated 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induction of human NAD(P)H: quinone oxidoreductase 1 gene expression. Biochem Pharmacol 58: 1649-1655. (Pubitemid 29467351)
174. Rawlings, J. S., Rosler, K. M., Harrison, D. A. (2004). The JAK/STAT signaling pathway. J Cell Sci 117(Pt 8): 1281-1283. (Pubitemid 38559804)
175. Reiners, J. J. Jr, Schöller, A., Bischer, P., Cantu, A. R., Pavone, A. (1993). Suppression of cytochrome P450 Cyp1a-1 induction in murine hepatoma 1c1c7 cells by 12-O-tetradecanoylphorbol-13-acetate and inhibitors of protein kinase C. Arch Biochem Biophys 301: 449-454. (Pubitemid 23214145)
176. Renton, K. W. (2001). Alteration of drug biotransformation and elimination during infection and inflammation. Pharmacol Ther 92: 147-163. (Pubitemid 34251132)
177. Renton, K. W. (2005). Regulation of drug metabolism and disposition during inflammation and infection. Expert Opin Drug Metab Toxicol 1: 629-640.
178. Renton, K. W., Keyler, D. E., Mannering, G. J. (1979). Suppression of the inductive effects of phenobarbital and 3-methylcholanthrene on ascorbic acid synthesis and hepatic cytochrome P-450-linked monooxygenase systems by the interferon inducers, poly rI.rC and tilorone. Biochem Biophys Res Commun 88: 1017-1023. (Pubitemid 9204824)
179. Richardson, T. A., Morgan, E. T. (2005). Hepatic cytochrome P450 gene regulation during endotoxin-induced inflammation in nuclear receptor knockout mice. J Pharmacol Exp Ther 314: 703-709. (Pubitemid 41043852)
180. Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., Glass, C. K. (1998). The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 391: 79-82. (Pubitemid 28079218)
181. Rizzardini, M., Zappone, M., Villa, P., Gnocchi, P., Sironi, M., Diomede, L. et al. (1998). Kupffer cell depletion partially prevents hepatic heme oxygenase 1 messenger RNA accumulation in systemic inflammation in mice: role of interleukin 1beta. Hepatology 27: 703-710. (Pubitemid 28103546)
182. Roberts, R. A., Ganey, P. E., Ju, C., Kamendulis, L. M., Rusyn, I., Klaunig, J. E. (2007). Role of the Kupffer cell in mediating hepatic toxicity and carcinogenesis. Toxicol Sci 96: 2-15. (Pubitemid 46323203)
183. Rochette-Egly, C. (2003). Nuclear receptors: integration of multiple signalling pathways through phosphorylation. Cellular Signalling 15: 355-366. (Pubitemid 36254908)
184. Roos, P. H., Bolt, H. M. (2005). Cytochrome P450 interactions in human cancers: new aspects considering CYP1B1. Expert Opin Drug Metab Toxicol 1: 187-202.
185. Ross, D. (2004). Quinone reductases multitasking in the metabolic world. Drug Metab Rev 36: 639-654. (Pubitemid 39453067)
186. Roy-Chowdhury, J., Locker, J., Roy-Chowdhury, N. (2003). Nuclear receptors orchestrate detoxification pathways. Developmental Cell 4: 607-608.
187. Ryu, S. D., Yi, H. G., Cha, Y. N., Kang, J. H., Kang, J. S., Jeon, Y. C. et al. (2004). Flavin-containing monooxygenase activity can be inhibited by nitric oxide-mediated S-nitrosylation. Life Sciences 75: 2559-2572.
188. Sachdeva, K., Yan, B., Chichester, C. O. (2003). Lipopolysaccharide and cecal ligation/puncture differentially affect the subcellular distribution of the pregnane X receptor but consistently cause suppression of its target genes CYP3A. Shock (Augusta, Ga.) 19: 469-474. (Pubitemid 44305175)
189. Samaras, S. C., Dietz, N. (1953). Physiopathology of detoxication of pentobarbital sodium. Fed Am Soc Exp Biol 12: 400.
190. Schmith, V. D., Foss, J. F. (2008). Effects of inflammation on pharmacokinetics/pharmacodynamics: increasing recognition of its contribution to variability in response. Clin Pharmacol Ther 83: 809-811. (Pubitemid 351704932)
191. Schote, A. B., Turner, J. D., Schiltz, J., Muller, C. P. (2007). Nuclear receptors in human immune cells: expression and correlations. Mol Immunol 44: 1436-1445. (Pubitemid 44415949)
192. Schuetz, J. D., Schuetz, E. G., Thottassery, J. V., Guzelian, P. S., Strom, S., Sun, D. (1996). Identification of a novel dexamethasone responsive enhancer in the human CYP3A5 gene and its activation in human and rat liver cells. Mol Pharmacol 49: 63-72. (Pubitemid 26036785)
193. Sciullo, E. M., Vogel, C. F., Li, W., Matsumura, F. (2008). Initial and extended inflammatory messages of the nongenomic signaling pathway of the TCDD-activated Ah receptor in U937 macrophages. Arch Biochem Biophys 480: 143-155.
194. Sekine, H., Mimura, J., Oshima, M., Okawa, H., Kanno, J., Igarashi, K. et al. (2009). Hypersensitivity of aryl hydrocarbon receptordeficient mice to lipopolysaccharide-induced septic shock. Mol Cell Biol 29: 6391-6400.
195. Shah, Y. M., Ma, X., Morimura, K., Kim, I., Gonzalez, F. J. (2007). Pregnane X receptor activation ameliorates DSS-induced inflammatory bowel disease via inhibition of NF-kappaB target gene expression. Am J Physiol Gastrointest Liver Physiol 292: G1114-G1122. (Pubitemid 46557773)
196. Sheppard, K. A., Phelps, K. M., Williams, A. J., Thanos, D., Glass, C. K., Rosenfeld, M. G. et al. (1998). Nuclear integration of glucocorticoid receptor and nuclear factor-kappaB signaling by CREBbinding protein and steroid receptor coactivator-1. J Biol Chem 273: 29291-29294. (Pubitemid 28509926)
197. Sheppard, K. A., Rose, D. W., Haque, Z. K., Kurokawa, R., McInerney, E., Westin, S. et al. (1999). Transcriptional activation by NF-kappaB requires multiple coactivators. Mol Cell Biol 19: 6367-6378. (Pubitemid 29399341)
198. Shi, L. Z., Faith, N. G., Nakayama, Y., Suresh, M., Steinberg, H., Czuprynski, C. J. (2007). The aryl hydrocarbon receptor is required for optimal resistance to Listeria monocytogenes infection in mice. J Immunol 179: 6952-6962.
199. Shibazaki, M., Takeuchi, T., Ahmed, S., Kikuchia, H. (2004). Blockade by SB203580 of Cyp1a1 induction by 2,3,7,8-tetrachlorodibenzop-dioxin, and the possible mechanism: possible involvement of the p38 mitogen-activated protein kinase pathway in shuttling of Ah receptor overexpressed in COS-7 cells. Ann N Y Acad Sci 1030: 275-281. (Pubitemid 40378923)
200. Shin, S., Wakabayashi, N., Misra, V., Biswal, S., Lee, G. H., Agoston, E. S. et al. (2007). NRF2 modulates aryl hydrocarbon receptor signaling: influence on adipogenesis. Mol Cell Biol 27: 7188-7197. (Pubitemid 47549754)
201. Siewert, E., Bort, R., Kluge, R., Heinrich, P. C., Castell, J., Jover, R. (2000). Hepatic cytochrome P450 down-regulation during aseptic inflammation in the mouse is interleukin 6 dependent. Hepatology 32: 49-55. (Pubitemid 30432365)
202. Sissung, T. M., Price, D. K., Sparreboom, A., Figg, W. D. (2006). Pharmacogenetics and regulation of human cytochrome P450 1B1: implications in hormone-mediated tumor metabolism and a novel target for therapeutic intervention. Molecular Cancer Research: Mcr 4: 135-150.
203. Slaviero, K. A., Clarke, S. J., Rivory, L. P. (2003). Inflammatory response: an unrecognised source of variability in the pharmacokinetics and pharmacodynamics of cancer chemotherapy. Lancet Oncol 4: 224-232. (Pubitemid 36503320)
204. Sorrell, T. C., Forbes, I. J. (1975). Depression of immune competence by phenytoin and carbamazepine. Studies in vivo and in vitro. Clinical and Experimental Immunology 20: 273-285.
205. Staudinger, J. L., Xu, C., Biswas, A., Mani, S. (2011). Post-translational modification of pregnane x receptor. Pharmacol Res 64: 4-10.
206. Stevens, E. A., Mezrich, J. D., Bradfield, C. A. (2009). The aryl hydrocarbon receptor: a perspective on potential roles in the immune system. Immunology 127: 299-311.
207. Stoltz, C., Anderson, A. (1999). Positive regulation of the rat CYP2B2 phenobarbital response unit by the nuclear receptor hexamer halfsite. nuclear factor 1 complex. Biochem Pharmacol 57: 1073-1076. (Pubitemid 29168556)
208. Sueyoshi, T., Kawamoto, T., Zelko, I., Honkakoski, P., Negishi, M. (1999). The repressed nuclear receptor CAR responds to phenobarbital in activating the human CYP2B6 gene. J Biol Chem 274: 6043-6046. (Pubitemid 29111006)
209. Sugita-Konishi, Y., Kobayashi, K., Naito, H., Miura, K., Suzuki, Y. (2003). Effect of lactational exposure to 2,3,7,8-tetrachlorodibenzo-pdioxin on the susceptibility to Listeria infection. Biosci Biotechnol Biochem 67: 89-93. (Pubitemid 39260149)
210. Sun, S. C. (2012). The noncanonical NF-B pathway. Immunol Rev 246: 125-140.
211. Tan, Z., Chang, X., Puga, A., Xia, Y. (2002). Activation of mitogenactivated protein kinases (MAPKs) by aromatic hydrocarbons: role in the regulation of aryl hydrocarbon receptor (AHR) function. Biochem Pharmacol 64: 771-780. (Pubitemid 35232250)
212. Tan, Z., Huang, M., Puga, A., Xia, Y. (2004). A critical role for MAP kinases in the control of Ah receptor complex activity. Toxicol Sci 82: 80-87. (Pubitemid 39485322)
213. Teng, S., Piquette-Miller, M. (2005). The involvement of the pregnane X receptor in hepatic gene regulation during inflammation in mice. J Pharmacol Exp Ther 312: 841-848. (Pubitemid 40189587)
214. Theken, K. N., Deng, Y., Kannon, M. A., Miller, T. M., Poloyac, S. M., Lee, C. R. (2011). Activation of the acute inflammatory response alters cytochrome P450 expression and eicosanoid metabolism. Drug Metab Dispos 39: 22-29.
215. Tian, Y. (2009). Ah receptor and NF-kappaB interplay on the stage of epigenome. Biochem Pharmacol 77: 670-680.
216. Tian, Y., Ke, S., Chen, M., Sheng, T. (2003). Interactions between the aryl hydrocarbon receptor and P-TEFb. Sequential recruitment of transcription factors and differential phosphorylation of C-terminal domain of RNA polymerase II at cyp1a1 promoter. J Biol Chem 278: 44041-44048. (Pubitemid 37377144)
217. Tian, Y., Ke, S., Denison, M. S., Rabson, A. B., Gallo, M. A. (1999). Ah receptor and NF-kappaB interactions, a potential mechanism for dioxin toxicity. J Biol Chem 274: 510-515. (Pubitemid 29035090)
218. Tian, Y., Rabson, A. B., Gallo, M. A. (2002). Ah receptor and NF-kappaB interactions: mechanisms and physiological implications. Chem Biol Interact 141: 97-115. (Pubitemid 35223207)
219. Tirona, R. G., Lee, W., Leake, B. F., Lan, L. B., Cline, C. B., Lamba, V. et al. (2003). The orphan nuclear receptor HNF4alpha determines PXR-and CAR-mediated xenobiotic induction of CYP3A4. Nat Med 9: 220-224. (Pubitemid 36227725)
220. Umannová, L., Machala, M., Topinka, J., Nováková, Z., Milcová, A., Kozubík, A. et al. (2008). Tumor necrosis factor-alpha potentiates genotoxic effects of benzo[a]pyrene in rat liver epithelial cells through upregulation of cytochrome P450 1B1 expression. Mutat Res 640: 162-169.
221. Umannová, L., Machala, M., Topinka, J., Schmuczerová, J., Krcmár, P., Neca, J. et al. (2011). Benzo[a]pyrene and tumor necrosis factor-a coordinately increase genotoxic damage and the production of proinflammatory mediators in alveolar epithelial type II cells. Toxicol Lett 206: 121-129.
222. Umannová, L., Zatloukalová, J., Machala, M., Krcmár, P., Májková, Z., Hennig, B. et al. (2007). Tumor necrosis factor-alpha modulates effects of aryl hydrocarbon receptor ligands on cell proliferation and expression of cytochrome P450 enzymes in rat liver "stemlike" cells. Toxicol Sci 99: 79-89. (Pubitemid 47250369)
223. Urquhart, B. L., Tirona, R. G., Kim, R. B. (2007). Nuclear receptors and the regulation of drug-metabolizing enzymes and drug transporters: implications for interindividual variability in response to drugs. J Clin Pharmacol 47: 566-578. (Pubitemid 46632158)
224. Van Bogaert, T., De Bosscher, K., Libert, C. (2010). Crosstalk between TNF and glucocorticoid receptor signaling pathways. Cytokine Growth Factor Rev 21: 275-286.
225. Van Voorhis, B. J., Anderson, D. J., Hill, J. A. (1989). The effects of RU 486 on immune function and steroid-induced immunosuppression in vitro. J Clin Endocrinol Metab 69: 1195-1199. (Pubitemid 20010047)
226. Veldhoen, M., Hirota, K., Westendorf, A. M., Buer, J., Dumoutier, L., Renauld, J. C. et al. (2008). The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 453: 106-109. (Pubitemid 351630329)
227. Venteclef, N., Jakobsson, T., Steffensen, K. R., Treuter, E. (2011). Metabolic nuclear receptor signaling and the inflammatory acute phase response. Trends Endocrinol Metab 22: 333-343.
228. Vogel, C. F., Matsumura, F. (2009). A new cross-talk between the aryl hydrocarbon receptor and RelB, a member of the NF-kappaB family. Biochem Pharmacol 77: 734-745.
229. Vogel, C. F., Nishimura, N., Sciullo, E., Wong, P., Li, W., Matsumura, F. (2007a). Modulation of the chemokines KC and MCP-1 by 2,3,7,8- tetrachlorodibenzo-p-dioxin (TCDD) in mice. Arch Biochem Biophys 461: 169-175. (Pubitemid 46677883)
230. Vogel, C. F., Sciullo, E., Li, W., Wong, P., Lazennec, G., Matsumura, F. (2007b). RelB, a new partner of aryl hydrocarbon receptormediated transcription. Mol Endocrinol 21: 2941-2955. (Pubitemid 350223506)
231. Vogel, C. F., Sciullo, E., Matsumura, F. (2007c). Involvement of RelB in aryl hydrocarbon receptor-mediated induction of chemokines. Biochem Biophys Res Commun 363: 722-726. (Pubitemid 47513689)
232. Vondrácek, J., Umannová, L., Machala, M. (2011). Interactions of the aryl hydrocarbon receptor with inflammatory mediators: beyond CYP1A regulation. Curr Drug Metab 12: 89-103.
233. Wagner, M., Zollner, G., Trauner, M. (2011). Nuclear receptors in liver disease. Hepatology 53: 1023-1034.
234. Wallace, K., Cowie, D. E., Konstantinou, D. K., Hill, S. J., Tjelle, T. E., Axon, A. et al. (2010). The PXR is a drug target for chronic inflammatory liver disease. J Steroid Biochem Mol Biol 120: 137-148.
235. Wan, Y. J., An, D., Cai, Y., Repa, J. J., Hung-Po Chen, T., Flores, M. et al. (2000). Hepatocyte-specific mutation establishes retinoid X receptor alpha as a heterodimeric integrator of multiple physiological processes in the liver. Mol Cell Biol 20: 4436-4444. (Pubitemid 30346638)
236. Warren, G. W., Poloyac, S. M., Gary, D. S., Mattson, M. P., Blouin, R. A. (1999). Hepatic cytochrome P-450 expression in tumor necrosis factor-alpha receptor (p55/p75) knockout mice after endotoxin administration. J Pharmacol Exp Ther 288: 945-950. (Pubitemid 29254130)
237. Watkins, L. R., Maier, S. F., Goehler, L. E. (1995). Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain 63: 289-302.
238. Watt, A. J., Garrison, W. D., Duncan, S. A. (2003). HNF4: a central regulator of hepatocyte differentiation and function. Hepatology 37: 1249-1253. (Pubitemid 36667301)
239. Weiss, C., Faust, D., Dürk, H., Kolluri, S. K., Pelzer, A., Schneider, S. et al. (2005). TCDD induces c-jun expression via a novel Ah (dioxin) receptor-mediated p38-MAPK-dependent pathway. Oncogene 24: 4975-4983. (Pubitemid 41129101)
240. Wu, D., Li, W., Lok, P., Matsumura, F., Vogel, C. F. (2011). AhR deficiency impairs expression of LPS-induced inflammatory genes in mice. Biochem Biophys Res Commun 410: 358-363.
241. Wu, R., Cui, X., Dong, W., Zhou, M., Simms, H. H., Wang, P. (2006). Suppression of hepatocyte CYP1A2 expression by Kupffer cells via AhR pathway: the central role of proinflammatory cytokines. Int J Mol Med 18: 339-346.
242. Xu, D. X., Wei, W., Sun, M. F., Wei, L. Z., Wang, J. P. (2005). Melatonin attenuates lipopolysaccharide-induced down-regulation of pregnane X receptor and its target gene CYP3A in mouse liver. J Pineal Res 38: 27-34. (Pubitemid 40139307)
243. Xu, D. X., Wei, W., Sun, M. F., Wu, C. Y., Wang, J. P., Wei, L. Z. et al. (2004). Kupffer cells and reactive oxygen species partially mediate lipopolysaccharide-induced downregulation of nuclear receptor pregnane x receptor and its target gene CYP3a in mouse liver. Free Radic Biol Med 37: 10-22. (Pubitemid 38746647)
244. Yamamoto, Y., Moore, R., Flavell, R. A., Lu, B., Negishi, M. (2010). Nuclear receptor CAR represses TNFalpha-induced cell death by interacting with the anti-apoptotic GADD45B. Plos One 5: e10121.
245. Yamamoto, Y., Negishi, M. (2008). The antiapoptotic factor growth arrest and DNA-damage-inducible 45 beta regulates the nuclear receptor constitutive active/androstane receptor-mediated transcription. Drug Metab Dispos 36: 1189-1193. (Pubitemid 351929329)
246. Yang-Yen, H. F., Chambard, J. C., Sun, Y. L., Smeal, T., Schmidt, T. J., Drouin, J. et al. (1990). Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 62: 1205-1215.
247. Yang, J., Hao, C., Yang, D., Shi, D., Song, X., Luan, X. et al. (2010). Pregnane X receptor is required for interleukin-6-mediated downregulation of cytochrome P450 3A4 in human hepatocytes. Toxicol Lett 197: 219-226.
248. Yang, Q., Shi, Y., He, J., Chen, Z. (2012). The evolving story of macrophages in acute liver failure. Immunol Lett 147: 1-9.
249. Yeager, R. L., Reisman, S. A., Aleksunes, L. M., Klaassen, C. D. (2009). Introducing the "TCDD-inducible AhR-Nrf2 gene battery". Toxicol Sci 111: 238-246.
250. Zassadowski, F., Rochette-Egly, C., Chomienne, C., Cassinat, B. (2012). Regulation of the transcriptional activity of nuclear receptors by the MEK/ERK1/2 pathway. Cell Signal 24: 2369-2377.
251. Zhang, J., Chaluvadi, M. R., Reddy, R., Motika, M. S., Richardson, T. A., Cashman, J. R. et al. (2009). Hepatic flavin-containing monooxygenase gene regulation in different mouse inflammation models. Drug Metab Dispos 37: 462-468.
252. Zhou, C., Tabb, M. M., Nelson, E. L., Grün, F., Verma, S., Sadatrafiei, A. et al. (2006). Mutual repression between steroid and xenobiotic receptor and NF-kappaB signaling pathways links xenobiotic metabolism and inflammation. J Clin Invest 116: 2280-2289. (Pubitemid 44162338)
253. Zhou, M., Maitra, S. R., Wang, P. (2008). The potential role of transcription factor aryl hydrocarbon receptor in downregulation of hepatic cytochrome P-450 during sepsis. Int J Mol Med 21: 423-428. (Pubitemid 351802636)
254. Zimmerman, T. L., Thevananther, S., Ghose, R., Burns, A. R., Karpen, S. J. (2006). Nuclear export of retinoid X receptor alpha in response to interleukin-1beta-mediated cell signaling: roles for JNK and SER260. J Biol Chem 281: 15434-15440. (Pubitemid 43855135)
255. Zollner, G., Wagner, M., Trauner, M. (2010). Nuclear receptors as drug targets in cholestasis and drug-induced hepatotoxicity. Pharmacol Ther 126: 228-243.